Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from China NT Pharma Group Co., Ltd. ( (HK:1011) ).
China NT Pharma Group Co., Ltd. announced that all resolutions proposed at their Annual General Meeting (AGM) held on June 30, 2025, were passed by shareholders. The resolutions included the adoption of financial statements, re-election of directors, appointment of auditors, and granting of mandates related to share issuance and repurchase. This successful AGM reflects strong shareholder support and positions the company for continued operational stability and strategic growth.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is known for its work in the healthcare sector, particularly in China, where it aims to provide quality medical solutions.
Average Trading Volume: 1,341,530
Technical Sentiment Signal: Buy
Current Market Cap: HK$269.7M
See more insights into 1011 stock on TipRanks’ Stock Analysis page.